TY - JOUR
T1 - Role of the endothelium in modulating neointimal formation
T2 - Vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions
AU - Kipshidze, Nicholas
AU - Dangas, George
AU - Tsapenko, Mykola
AU - Moses, Jeffrey
AU - Leon, Martin B.
AU - Kutryk, Michael
AU - Serruys, Patrick
N1 - Funding Information:
Dr. Kipshidze is a consultant to AVI-Biopharma and a major stockholder in EVT. Dr. Dangas is a consultant to Cordis and Guidant, receives research grant support from Cordis and Boston Scientific, and receives speaker honoraria from Cordis. Dr. Kutryk is a consultant and Drs. Serruys and Leon are scientific advisers to Orbus Medical Technologies. Drs. Leon and Moses receive honoraria for speaking engagements from and have common stock holdings in Cordis, a Johnson & Johnson Company.
PY - 2004/8/18
Y1 - 2004/8/18
N2 - Restenosis at the site of an endoluminal procedure remains a significant problem in the practice of interventional cardiology. We present current data on intimal hyperplasia, which identify the major role of endothelial cells (ECs) in the development of restenosis. Considering endothelial denudation as one of the most important mechanisms contributing to restenosis, we focus more attention on methods of accelerating restoration of endothelial continuity. Prevention of restenosis may be achieved by promoting endothelial regeneration through the use of growth factors, EC seeding, vessel reconstruction with autologous EC/fibrin matrix, and the use of estrogen-loaded stents and stents designed to capture progenitor ECs.
AB - Restenosis at the site of an endoluminal procedure remains a significant problem in the practice of interventional cardiology. We present current data on intimal hyperplasia, which identify the major role of endothelial cells (ECs) in the development of restenosis. Considering endothelial denudation as one of the most important mechanisms contributing to restenosis, we focus more attention on methods of accelerating restoration of endothelial continuity. Prevention of restenosis may be achieved by promoting endothelial regeneration through the use of growth factors, EC seeding, vessel reconstruction with autologous EC/fibrin matrix, and the use of estrogen-loaded stents and stents designed to capture progenitor ECs.
UR - http://www.scopus.com/inward/record.url?scp=4143131081&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2004.04.048
DO - 10.1016/j.jacc.2004.04.048
M3 - Review article
C2 - 15312851
AN - SCOPUS:4143131081
SN - 0735-1097
VL - 44
SP - 733
EP - 739
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 4
ER -